4.3 Article

Asymptomatic progressive multifocal leukoencephalopathy during natalizumab therapy with treatment

Journal

JOURNAL OF CLINICAL NEUROSCIENCE
Volume 25, Issue -, Pages 145-147

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.jocn.2015.08.027

Keywords

Immune reconstitution inflammatory syndrome; Multiple sclerosis; Natalizumab; Progressive multifocal leukoencephalopathy

Funding

  1. Sun Yat Sen University Occupational Training Scholarship
  2. International Project Fund of 985 Project
  3. Sun Yat Sen University

Ask authors/readers for more resources

We report a case of asymptomatic progressive multifocal leukoencephalopathy (PML) detected on regular MRI screening in a 40-year-old patient with subsequent benign course with 12 months follow-up. The patient had a history of aggressive inflammatory multiple sclerosis, prior mitoxantrone therapy, Stratify John Cunningham Virus test positivity (Quest Diagnostics, Madison, NJ, USA), and 5 years of natalizumab monotherapy. The initial MRI detection of PML was both atypical and subtle. Early diagnosis and intervention, and pre-emptive treatment for immune reconstitution inflammatory syndrome with high dose steroids, as well as empirical mirtazapine and mefloquine, were associated with a benign PML disease course and outcome. (C) 2015 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available